scholarly journals Vena cava superior syndrome. Analisis of interventional and medical treatment options

2021 ◽  
Vol 1 ◽  
pp. 19-24
Author(s):  
Iveta Tasheva ◽  
Sibel Kafalieva

We present a clinical case of a 72-year-old man with a history of hypertension and SARS-CoV-2 infection, urgently hospitalized in the intensive care unit due to dyspnea at rest, blushes and swelling of the neck and face, headache, and syncope. Echocardiography was performed and revealed preserved ejection fraction of left and right ventricle (EF – 57%, TAPSE – 21 mm), without hemodynamically significant valve lesions and normal ECG. On the next day of hospitalization, we performed a computer tomography (CT) scan of the lungs and it showed a tumor in right lung, compressing vena cava superior. Venography was performed and revealed subtotal thrombosis of vena cava superior and stenting with Wallstent 16/60 mm was performed. Six hours after the intervention a clinical improvement was achieved – reducing of the swelling and relieving of the symptoms.

2015 ◽  
Vol 2 (2) ◽  
pp. 149-153 ◽  
Author(s):  
M.Yu. Rykov ◽  
◽  
О.А. Kirillova ◽  
V.V. Dailidite ◽  
N.N. Subbotina ◽  
...  

2009 ◽  
Vol 20 ◽  
pp. S120
Author(s):  
Ayse Nur Tufan ◽  
Omer Kaya ◽  
Hande Bektas ◽  
Fatih Tufan ◽  
Selim Yavuz ◽  
...  

Renal Failure ◽  
2012 ◽  
Vol 34 (2) ◽  
pp. 244-246 ◽  
Author(s):  
Karel Matousovic ◽  
Vojtech Martinek ◽  
Jaroslav Špatenka ◽  
Josef Stejskal ◽  
Maria Chadimova

Author(s):  
Lale SERTÇELİK ◽  
Fatma Armağan HAZAR ◽  
Mine DEMİR ◽  
İpek ERDEM ◽  
Aysun KOSİF

2021 ◽  
Vol 8 (3) ◽  
pp. 61-69
Author(s):  
Aysegul YILDIRIM ◽  

Author(s):  
Sita Ro'yul Aini ◽  
Laksmi Wulandari ◽  
Susilowati Andajani

A B S T R A C TMethods: This research was a descriptive observational study. The samples were 240 patients of lung cancer in Poly Oncology Dr. Soetomo General Hospital Surabaya 2016-2017. Sampling technique was non-random sampling (consecutive sampling). The variables were: age, sex, smoking habits, type of lung cancer, type of mutation, stage, symptoms, Vena Cava Superior syndrome, and therapy. The data analyzed were analyzed descriptively.Results: Patients mostly at age 51-55 and 56-60 years old (18% each). Ratio men and women are 1,7:1. In all type of lung cancer, men are dominant than women and mostly patients is active smoker. Ephidermal Growth Factor Receptor (EGFR) mutation found in adenosquamous (75%) and adenocarcinoma (65%). Most patients diagnosed at advance stage. Most symptoms are cough (70.4%), dyspnoea (50%), and chest pain (49.2%). Vena Cava Superior Syndrome (VCSS) found in adenocarcinoma (75%) and squamous cell carcinoma (25%). In adenocarcinoma and adenosquamous, patients commonly got targeted therapy.Conclusion: Lung cancer patients: 1) Men tend to be exposed to younger than women, 2) ratio men and women is 1.7:1 and most type in lung cancer is adenocarcinoma 3) mostly patients is active smoker, 4) EGFR mutation tent to be in women with adenocarcinoma, 5) most stage is stage IV, 6) most symptoms is cough, 7) Vena Cava Superior Syndrome is in adenocarcinoma (75%) and carcinoma cell squamous (25%), 8) patients’ therapy mostly with targeted therapy followed by chemotherapy.


Sign in / Sign up

Export Citation Format

Share Document